Fecal Carriage of ESBL-Producing E. coli and K. pneumoniae in Children in Guinea-Bissau: A Hospital-Based Cross-Sectional Study

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Isendahl, Joakim ^a   Turlej Rogacka, Agata ^a   Manjuba, Cristovão ^b   Rodrigues, Amabelia ^c   Giske, Christian G ^a   Nauclér, Pontus ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Hospital Nacional Simao Mendes   (Guinea-Bissau)

^c Instituto Nacional da Saúde Pública   (Guinea-Bissau)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLACTX M 1 GENE; CHILD; CLONAL VARIATION; CROWDING; DISK DIFFUSION; EMERGENCY WARD; ENZYME SYNTHESIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES ANALYSIS; FECES CULTURE; FEMALE; GENETIC CODE; GRAM NEGATIVE SEPSIS; GUINEA-BISSAU; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CROSS-SECTIONAL STUDIES; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FECES; GUINEA-BISSAU; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RISK FACTORS;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; NEGIBACTERIA;

EID: 84871426389     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051981     Document Type: Article

References (37)

1. Levy SB, Marshall B, (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10: S122-129.
2. Livermore DM, (2008) Defining an extended-spectrum beta-lactamase. Clin Microbiol Infect 14Suppl 1: 3-10.
3. Kariuki S, Hart CA, (2001) Global aspects of antimicrobial-resistant enteric bacteria. Curr Opin Infect Dis 14: 579-586.
4. Falagas ME, Karageorgopoulos DE, (2009) Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect 73: 345-354.
5. Canton R, Coque TM, (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9: 466-475.
6. Pitout JD, Laupland KB, (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8(3): 159-166.
7. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P, (2005) Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 49: 71-76.
8. Paterson DL (2006) Resistance in gram-negative bacteria: enterobacteriaceae. Am J Med 119: S20-28; discussion S62-70.
9. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, et al. (2006) Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42: 657-668.
10. Schwaber MJ, Carmeli Y, (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60: 913-920.
11. Livermore D, (2012) Current Epidemiology and Growing Resistance of Gram-Negative Pathogens. Korean J Intern Med 27: 128-142.
12. Weisenberg SA, Mediavilla JR, Chen L, Alexander EL, Rhee KY, et al. (2012) Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae in International Travelers and Non-Travelers in New York City. PLoS ONE 7(9): e45141.
13. Luvsansharav UO, Hirai I, Nakata A, Imura K, Yamauchi K, et al. (2012) Prevalence and risk factors associated with faecal carriage of CTX-M beta-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother 67: 1769-1774.
14. Wickramasinghe NH, Xu L, Eustace A, Shabir S, Saluja T, et al. (2012) High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. J Antimicrob Chemother 67: 1108-1113.
15. Rodriguez-Baño J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A, (2008) Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother 62: 1142-1149.
16. Peirano G, Laupland KB, Gregson DB, Pitout JD, (2011) Colonization of Returning Travelers With CTX-M-Producing Escherichia coli. J Travel Med 18: 299-303.
17. Andriatahina T, Randrianirina F, Hariniana ER, Talarmin A, Raobijaona H, et al. (2010) High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar. BMC Infect Dis 10: 204.
18. Herindrainy P, Randrianirina F, Ratovoson R, Ratsima Hariniana E, Buisson Y, et al. (2011) Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar. PLoS ONE 6: e22738.
19. Woerther PL, Angebault C, Jacquier H, Hugede HC, Janssens AC, et al. (2011) Massive increase, spread, and exchange of extended spectrum beta-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin Infect Dis 53: 677-685.
20. Abdul Rahman EM, El-Sherif RH, (2011) High rates of intestinal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae among healthy individuals. J Investig Med 59: 1284-1286.
21. Lonchel CM, Meex C, Gangoue-Pieboji J, Boreux R, Assoumou MC, et al. (2012) Proportion of extended-spectrum beta-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect Dis 12: 53.
22. United Nations Department of Economic and Social Affairs, Statistics Division (2012) World Statistics Pocketbook 2011 Series V No. 36. New York: United Nations. p 87.
23. Reglier-Poupet H, Naas T, Carrer A, Cady A, Adam JM, et al. (2008) Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum beta-lactamases. J Med Microbiol 57: 310-315.
24. Sanders CC, Peyret M, Moland ES, Shubert C, Thomson KS, et al. (2000) Ability of the VITEK 2 advanced expert system to identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol 38: 570-574.
25. European Committee of Antimicrobial Susceptibility Testing (2012) Breakpoint tables for interpretation of MICs and zone diameters, version 2.0. Available: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_2.0_120221.pdf. Accessed: 15 October 2012.
26. Birkett CI, Ludlam HA, Woodford N, Brown DF, Brown NM, et al. (2007) Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases. J Med Microbiol 56: 52-55.
27. Bogaerts P, Hujer AM, Naas T, de Castro RR, Endimiani A, et al. (2011) Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from beta-lactam-resistant gram-negative bacteria. Antimicrob Agents Chemother 55: 4457-4460.
28. Brolund A, Haeggman S, Edquist PJ, Gezelius L, Olsson-Liljequist B, et al. (2010) The DiversiLab system versus pulsed-field gel electrophoresis: characterisation of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae. J Microbiol Methods 83: 224-230.
29. Freeman JT, McBride SJ, Nisbet MS, Gamble GD, Williamson DA, et al. (2012) Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Int J Infect Dis 16: e371-374.
30. Oteo J, Perez-Vazquez M, Campos J, (2010) Extended-spectrum beta-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23: 320-326.
31. Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, et al. (2008) Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob Agents Chemother 52: 3244-3252.
32. Mshana SE, Imirzalioglu C, Hain T, Domann E, Lyamuya EF, et al. (2011) Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania. Clin Microbiol Infect 17: 1279-1282.
33. Peirano G, van Greune CH, Pitout JD, (2011) Characteristics of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli from community hospitals in South Africa. Diagn Microbiol Infect Dis 69: 449-453.
34. Mora A, Blanco M, Lopez C, Mamani R, Blanco JE, et al. (2011) Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 37: 16-21.
35. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, et al. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281.
36. Namboodiri SS, Opintan JA, Lijek RS, Newman MJ, Okeke IN, (2011) Quinolone resistance in Escherichia coli from Accra, Ghana. BMC Microbiol 11: 44.
37. Dromigny JA, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD, (2005) Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. J Antimicrob Chemother 56: 236-239.